Slim StudioSlim Studio

PT-141

Sexual Health
·1025 Da·7 amino acids·C₅₀H₆₈N₁₄O₁₀
Peptide Database
2Mechanisms
3Benefits
15Studies

Bremelanotide is a synthetic cyclic heptapeptide derived from the melanocortin peptide hormone alpha-MSH (alpha-melanocyte-stimulating hormone). It is an active metabolite of melanotan II, differing by the absence of the C-terminal amide group.

SequenceAc-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-OH
Research Dosage Notes

FDA-approved dose is 1.75 mg subcutaneous injection, self-administered at least 45 minutes before anticipated sexual activity. Used as-needed (PRN), not daily. No more than 1 dose per 24 hours or 8 doses per month. Common side effects include nausea (40%), flushing (20%), and headache (11%).

Mechanisms of Action

2

Melanocortin receptor agonism

Strong

Acts as a non-selective agonist of melanocortin receptors MC1R, MC3R, MC4R, and MC5R, with primary activity at MC3R and MC4R in the central nervous system, particularly the hypothalamus.

Melanocortin / MC3R-MC4R signaling

Central nervous system activation of sexual desire

Strong

Initiates action in the hypothalamus via MC3R/MC4R activation, leading to downstream effects on sexual desire and arousal pathways. The exact downstream signaling cascade is not fully elucidated.

Hypothalamic sexual arousal pathway

Benefits

3
95

Treatment of hypoactive sexual desire disorder (HSDD)

Sexual Health

FDA-approved for premenopausal women with HSDD. Phase 3 RECONNECT trials demonstrated statistically significant increases in sexual desire and reductions in distress related to low sexual desire compared to placebo.

Strong
70

Erectile dysfunction support

Sexual Health

Studied in men for erectile dysfunction with a central mechanism of action distinct from PDE5 inhibitors. Shows potential in men who do not respond to conventional ED medications.

Moderate
85

Increased sexual arousal

Sexual Health

Promotes physiological arousal through central nervous system pathways rather than peripheral vascular mechanisms.

Strong

Research Studies

15
2025

This review evaluates pharmacologic treatments for female sexual dysfunction (FSD), focusing on hypo...

Clinical obstetrics and gynecology · Andrew How, Christopher Jowdy, Elli Novatcheva, Anita H Clay...

2025

This review aims to provide an overview of pharmacologic management for hypoactive sexual desire dis...

The Annals of pharmacotherapy · Donna Barakeh, Hadil Mdaihly, Lamis R Karaoui

2025

Erectile dysfunction (ED) pathophysiology involves complex interactions between vasculogenic, hormon...

Expert opinion on pharmacotherapy · Vishal Ila, Edoardo Pozzi, Miyuru Gamage, Ranjith Ramasamy

2024

Melanocortin Receptor Agonist Bremelanotide Induces Cell Death and Growth Inhibition in Glioblastoma Cells

Anticancer research · Shuhei Suzuki, Chifumi Kitanaka, Masashi Okada

2023

A large body of preclinical and clinical data shows that the central melanocortin system is a promis...

Nature reviews. Endocrinology · Patrick Sweeney, Luis E Gimenez, Ciria C Hernandez, Roger D ...

This database is for educational and research purposes only. It is not medical advice. Consult a healthcare professional before using any peptide or supplement.

Slim Studio - Metabolic Health, Programs & Recovery